Free Trial
OTC:ZOMDF

Zomedica (ZOMDF) Stock Price, News & Analysis

Zomedica logo
$0.04 0.00 (-2.20%)
As of 06/6/2025 03:59 PM Eastern

About Zomedica Stock (OTC:ZOMDF)

Key Stats

Today's Range
$0.04
$0.05
50-Day Range
$0.04
$0.06
52-Week Range
$0.02
$0.17
Volume
812,516 shs
Average Volume
5.33 million shs
Market Capitalization
$43.61 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Zomedica Corp., a veterinary health company, focuses on the unmet needs of clinical veterinarians by developing products for companion animals. The company engages in the development and commercialization of TRUFORMA platform, which offers point-of-care diagnostic products for disease states in dogs and cats; and PulseVet, provides for treatment of various musculoskeletal issues, such as broken bones, tendonitis, and torn ligaments in horses and small animals. It has collaboration agreements with Celsee, Inc. for the development and commercialization of liquid biopsy assays and related consumables for the detection of cancer in companion animals; and Seraph Biosciences, Inc. for development and markets a novel pathogen detection system. The company was formerly known as Zomedica Pharmaceuticals Corp. and changed its name to Zomedica Corp. in October 2020. Zomedica Corp. was founded in 2015 and is headquartered in Ann Arbor, Michigan.

Zomedica Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
6th Percentile Overall Score

ZOMDF MarketRank™: 

Zomedica scored higher than 6% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    There is not enough analysis data for Zomedica.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Zomedica is -0.40, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Zomedica is -0.40, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Percentage of Shares Shorted

    0.08% of the outstanding shares of Zomedica have been sold short.
  • Short Interest Ratio / Days to Cover

    Zomedica has a short interest ratio ("days to cover") of 0.3, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Zomedica has recently decreased by 13.68%, indicating that investor sentiment is improving significantly.
  • Dividend Yield

    Zomedica does not currently pay a dividend.

  • Dividend Growth

    Zomedica does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    0.08% of the outstanding shares of Zomedica have been sold short.
  • Short Interest Ratio / Days to Cover

    Zomedica has a short interest ratio ("days to cover") of 0.3, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Zomedica has recently decreased by 13.68%, indicating that investor sentiment is improving significantly.
  • Search Interest

    3 people have searched for ZOMDF on MarketBeat in the last 30 days. This is an increase of 200% compared to the previous 30 days.
  • MarketBeat Follows

    Only 1 people have added Zomedica to their MarketBeat watchlist in the last 30 days. This is a decrease of -86% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Zomedica insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    Only 5.58% of the stock of Zomedica is held by insiders.

  • Percentage Held by Institutions

    Only 8.95% of the stock of Zomedica is held by institutions.

  • Read more about Zomedica's insider trading history.
Receive ZOMDF Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Zomedica and its competitors with MarketBeat's FREE daily newsletter.

ZOMDF Stock News Headlines

Trump’s treachery
Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to move your money now.
Zomedica Corp. (ZOMDF)
See More Headlines

ZOMDF Stock Analysis - Frequently Asked Questions

Zomedica's stock was trading at $0.0580 at the start of the year. Since then, ZOMDF stock has decreased by 23.3% and is now trading at $0.0445.
View the best growth stocks for 2025 here
.

Shares of ZOMDF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Industry, Sector and Symbol

Stock Exchange
OTC
Industry
Pharmaceutical Preparations
Sub-Industry
Pharmaceutical Products
Current Symbol
OTC:ZOMDF
Previous Symbol
OTC:ZOMDF
Fax
N/A
Employees
50
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Price / Cash Flow
N/A
Price / Book
N/A

Miscellaneous

Free Float
N/A
Market Cap
$43.61 million
Optionable
N/A
Beta
1.56
7 Energy Stocks to Buy and Hold Forever Cover

With the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.

Get This Free Report

This page (OTC:ZOMDF) was last updated on 6/7/2025 by MarketBeat.com Staff
From Our Partners